Home / Inspections / 1264024

FDA Inspection 1264024 — Sanofi Pasteur Limited

Sanofi Pasteur Limited — FEI 3002888623

The FDA completed an inspection of Sanofi Pasteur Limited on March 18, 2025 in North York. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 18, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
North York (Canada)

Facility

Other inspections at this facility

  • 1182359 (VAI Fri Oct 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099275 (VAI Fri May 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 851779 (VAI Fri Sep 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 783865 (OAI Wed Apr 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources